59:
curve. When a child deviates from his or her previously established growth curve, investigation into the cause is generally warranted. Parameters used to analyze growth charts include weight velocity (defined as rate of change in weight over time), height velocity (defined as rate of change in stature over time), and whether someone's growth chart crosses percentiles. For instance, endocrine disorders can be associated with a decrease in height velocity and preserved weight velocity while normal growth variants are associated with a decrease in height and weight velocity that are proportional to each other. It's important to note that other parameters are more commonly used such as waist circumference for assessing obesity and skin fold difference for assessing malnutrition. Growth charts can also be compiled with a portion of the population deemed to have been raised in more or less ideal environments, such as nutrition that conforms to pediatric guidelines, and no
31:
67:
100:
for dissemination to healthcare systems abroad. In order to accommodate for heterogenous populations internationally, the WHO made an effort to gather data from different regions in every continent. Data used to calculate the CDC's growth chart percentiles was accumulated periodically since the 1960s
83:
follow distinct growth curves which deviate significantly from children without these conditions. As such, growth charts have been created to describe the expected growth patterns of several developmental conditions. Since there are differences in normal growth rates between breastfed and formula-fed
58:
of a child can be compared to the expected parameters of children of the same age and sex to determine whether the child is growing appropriately. Growth charts can also be used to predict the expected adult height and weight of a child because, in general, children maintain a fairly constant growth
533:
Dewey, KG; Peerson, JM; Brown, KH; Krebs, NF; Michaelsen, KF; Persson, LA; Salmenpera, L; Whitehead, RG; Yeung, DL (1995). "Growth of breast-fed infants deviates from current reference data: A pooled analysis of US, Canadian, and
European data sets. World Health Organization Working Group on Infant
120:
for children. MPH is given by (mother’s height + father’s height) divided by 2. MPH is unisex. Boys need an upward correction, girls need a downward correction. In view of an average height difference between adult men and women of 13 cm, TH for boys is usually given by MPH + 6.5cm, TH for girls by
455:
The CDC's growth chart is utilized from a population that consists of a representative population in the USA. Charts based on a specific race or ethnicity are not useful because of the growth chart progression can be attributed to socioeconomic factors. WHO launched a revised growth in 2006 chart
398:
One of the most common growth disorders, a growth deficiency can be due to either familial short stature or constitutional growth delay (CGD). Familial short stature is indicative when one or both parents are of a short stature, and the height and weight percentiles are under the 5 percentile
121:
MPH - 6.5cm. Alternatively, TH can be expressed in standard deviation scores (SDS), with TH_SDS = (mother’s height_SDS + father’s height_SDS) / 2. Yet, this calculation is incorrect as it needs adjustment to mid-population height. It is suggested to use the
105:. Updated and more comprehensive data was later used to revise the existing growth chart and construct the 2000 CDC growth charts. The revised growth charts include revision of the 14 existing charts as well as introduction of 2 new BMI-for-age charts.
399:
threshold. The child will be concordant with the mean parental height, and the bone age should be normal. Constitutional growth delays are marked by low height and weight percentiles as early as the first 4–6 months following birth.
74:
Growth charts are different for boys and girls, due in part to pubertal differences and disparity in final adult height. In addition, children born prematurely and children with chromosomal abnormalities such as
84:
babies, the World Health
Organization growth charts, which better reflect the growth pattern of the healthy, breastfed infant, are considered the standard for U.S. children under age two.
208:
46:
and other health care providers to follow a child's growth over time. Growth charts have been constructed by observing the growth of large numbers of healthy children over time. The
323:
868:
Kwun, Younghee; Kim, Su Jin; Lee, Jieun; Isojima, Tsuyoshi; Choi, Doo-Seok; Kim, Duk-Kyung; Huh, June; Kang, I.-Seok; Chang, MiSun; Cho, Sung Yoon; Sohn, Young Bae (July 2015).
353:
is another useful metric that complements a physician's use of a growth chart. It is particularly useful in working up growth abnormalities and can indicate a delay in onset of
102:
375:
Benign variant of normal height growth due to a delay in the onset of puberty. Expect a delayed bone age and a trajectory that is not on track for the target height.
456:
using children from Ghana, Oman, Norway, Brazil, India and the USA that substantiated the fact that growth is highly dependent on environmental factors.
116:
is often used to predict the target height of an individual based on the heights of the two biological parents. It can be used to calculate the
995:
669:
93:
390:
The combination of height and weight velocity can indicate underlying disease of genetic origin, endocrine cause, and/or delayed growth.
381:
Pathologic variant of normal growth due to hormonal abnormality. Expect a delayed height trajectory accompanied by a gain of weight.
134:
is another quantity that is used to quantify growth curves. It can be used for both height and weight. In the equation provided
491:
787:
739:
435:
A decrease of height velocity with retained or increased weight velocity can be indicative of endocrine disorders including
369:
Benign variant of normal height growth. Expect a normal bone age and a trajectory that is on track for the target height.
471:
30:
481:
218:
is a useful quantification that can gauge level of obesity. It is defined as follows with the given clinical ranges.
412:
486:
440:
407:
A variety of genetic syndromes can result growth chart patterns with a typical pattern. Genetic diseases such as
97:
152:
925:
982:
578:"Use of World Health Organization and CDC Growth Charts for Children Aged 0–59 Months in the United States"
419:
can be marked by a less than 5th percentile height and weight since birth. Other genetic disorders such as
96:(NCHS) in 1977 to clinically analyze child development. The 1977 growth chart was subsequently used by the
224:
60:
926:"Reference Population | Overview CDC Growth Charts | Growth Chart Training | NUtrition | DNPAO | CDC"
424:
715:
1014:
992:
559:
516:
55:
763:
907:
889:
850:
832:
665:
630:
551:
476:
465:
51:
897:
881:
840:
824:
657:
622:
543:
999:
420:
416:
408:
214:
80:
691:
649:
66:
902:
869:
845:
812:
444:
436:
1008:
76:
563:
47:
661:
595:
146:
represents change over a defined interval. Growth velocity is defined as follows.
692:"Constitutional Growth Delay: Practice Essentials, Pathophysiology, Epidemiology"
950:
885:
63:. Charts from these sources end up with slightly taller but thinner averages.
17:
43:
893:
836:
577:
610:
911:
828:
634:
34:
Sample growth chart for use with
American boys from birth to age 36 months.
854:
555:
547:
349:
496:
354:
328:
987:
626:
870:"Disease-specific Growth Charts of Marfan Syndrome Patients in Korea"
123:
conditional target height or cTH_SDS with a correction factor of 0.72
977:
648:
Bozzola, Mauro; Meazza, Cristina (2012), Preedy, Victor R. (ed.),
65:
29:
427:
are typically indicated by a height above the 90th percentile.
654:
Handbook of Growth and Growth
Monitoring in Health and Disease
650:"Growth Velocity Curves: What They Are and How to Use Them"
656:, New York, NY: Springer New York, pp. 2999–3011,
70:
Growth curve of a girl, compared to the 2006 WHO curves
227:
155:
317:
202:
103:National Health and Nutrition Examination Survey
768:NORD (National Organization for Rare Disorders)
611:"The calculation of target height reconsidered"
594:Centers for Disease Control (11 January 2019).
8:
92:The growth chart was first developed by the
203:{\displaystyle velocity=\Delta q/\Delta t}
901:
844:
309:
270:
226:
189:
154:
788:"Noonan syndrome - Symptoms and causes"
740:"Turner syndrome - Symptoms and causes"
508:
993:Growth Charts and Breastfeeding Babies
27:Graphic of child development over time
94:National Center for Health Statistics
88:History and revisions to growth chart
7:
338:: 85th < BMI < 95th percentile
318:{\displaystyle BMI=weight(kg)/^{2}}
596:"CDC Growth Charts: United States"
194:
183:
25:
874:Journal of Korean Medical Science
609:Hermanussen, M; Cole, M. (2003).
431:Endocrine and metabolic disorders
983:WHO information on growth charts
978:CDC information on growth charts
817:Archives of Disease in Childhood
361:Common variants of normal growth
492:Intrauterine growth restriction
988:The WHO Child Growth Standards
690:Clark, Pamela A (2024-07-10).
583:. Centers for Disease Control.
306:
302:
296:
275:
267:
258:
1:
716:"Constitutional Growth Delay"
662:10.1007/978-1-4419-1795-9_180
955:Center for Adoption Medicine
522:. World Health Organization.
517:"WHO Child Growth Standards"
472:Weight and height percentile
451:Variability in growth charts
373:Constitutional growth delay:
138:is either weight or height,
811:Hulse, J A (October 1988).
720:Pediatric Endocrine Society
482:Constitutional growth delay
1031:
886:10.3346/jkms.2015.30.7.911
332:: BMI > 95th percentile
487:Growth hormone deficiency
441:growth hormone deficiency
344:: BMI < 5th percentile
114:Mid-parental height (MPH)
98:World Health Organization
394:Normal growth deficiency
128:cTH_SDS = TH_SDS x 0.72
109:Quantitative definitions
813:"Special growth charts"
764:"Prader-Willi Syndrome"
367:Familial short stature:
829:10.1136/adc.63.10.1179
425:Klinefelter's syndrome
319:
204:
71:
35:
548:10.1542/peds.96.3.497
386:Clinical significance
320:
215:Body mass index (BMI)
205:
142:represents time, and
69:
33:
379:Endocrine disorders:
225:
153:
542:(3 Pt 1): 495–503.
468:, a growth disorder
998:2015-09-21 at the
696:Medscape Reference
315:
200:
118:target height (TH)
72:
56:head circumference
36:
823:(10): 1179–1180.
671:978-1-4419-1794-2
627:10.1159/000069321
477:Endocrine disease
466:Failure to thrive
421:Marfan's syndrome
409:Turner's syndrome
403:Genetic syndromes
16:(Redirected from
1022:
965:
964:
962:
961:
947:
941:
940:
938:
937:
922:
916:
915:
905:
865:
859:
858:
848:
808:
802:
801:
799:
798:
784:
778:
777:
775:
774:
760:
754:
753:
751:
750:
736:
730:
729:
727:
726:
712:
706:
705:
703:
702:
687:
681:
680:
679:
678:
645:
639:
638:
615:Hormone Research
606:
600:
599:
591:
585:
584:
582:
574:
568:
567:
530:
524:
523:
521:
513:
443:, and excess of
324:
322:
321:
316:
314:
313:
274:
209:
207:
206:
201:
193:
61:maternal smoking
21:
1030:
1029:
1025:
1024:
1023:
1021:
1020:
1019:
1005:
1004:
1000:Wayback Machine
974:
969:
968:
959:
957:
951:"Growth Charts"
949:
948:
944:
935:
933:
924:
923:
919:
867:
866:
862:
810:
809:
805:
796:
794:
786:
785:
781:
772:
770:
762:
761:
757:
748:
746:
738:
737:
733:
724:
722:
714:
713:
709:
700:
698:
689:
688:
684:
676:
674:
672:
647:
646:
642:
608:
607:
603:
593:
592:
588:
580:
576:
575:
571:
532:
531:
527:
519:
515:
514:
510:
505:
462:
453:
445:glucocorticoids
433:
417:Noonan syndrome
405:
396:
388:
363:
305:
223:
222:
151:
150:
111:
90:
81:Turner syndrome
28:
23:
22:
18:Growth velocity
15:
12:
11:
5:
1028:
1026:
1018:
1017:
1007:
1006:
1003:
1002:
990:
985:
980:
973:
972:External links
970:
967:
966:
942:
917:
880:(7): 911–916.
860:
803:
779:
755:
731:
707:
682:
670:
640:
621:(4): 180–183.
601:
586:
569:
525:
507:
506:
504:
501:
500:
499:
494:
489:
484:
479:
474:
469:
461:
458:
452:
449:
437:hypothyroidism
432:
429:
404:
401:
395:
392:
387:
384:
383:
382:
376:
370:
362:
359:
346:
345:
339:
333:
325:
312:
308:
304:
301:
298:
295:
292:
289:
286:
283:
280:
277:
273:
269:
266:
263:
260:
257:
254:
251:
248:
245:
242:
239:
236:
233:
230:
211:
210:
199:
196:
192:
188:
185:
182:
179:
176:
173:
170:
167:
164:
161:
158:
110:
107:
89:
86:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
1027:
1016:
1013:
1012:
1010:
1001:
997:
994:
991:
989:
986:
984:
981:
979:
976:
975:
971:
956:
952:
946:
943:
931:
927:
921:
918:
913:
909:
904:
899:
895:
891:
887:
883:
879:
875:
871:
864:
861:
856:
852:
847:
842:
838:
834:
830:
826:
822:
818:
814:
807:
804:
793:
789:
783:
780:
769:
765:
759:
756:
745:
741:
735:
732:
721:
717:
711:
708:
697:
693:
686:
683:
673:
667:
663:
659:
655:
651:
644:
641:
636:
632:
628:
624:
620:
616:
612:
605:
602:
597:
590:
587:
579:
573:
570:
565:
561:
557:
553:
549:
545:
541:
537:
529:
526:
518:
512:
509:
502:
498:
495:
493:
490:
488:
485:
483:
480:
478:
475:
473:
470:
467:
464:
463:
459:
457:
450:
448:
446:
442:
438:
430:
428:
426:
422:
418:
414:
410:
402:
400:
393:
391:
385:
380:
377:
374:
371:
368:
365:
364:
360:
358:
356:
352:
351:
343:
340:
337:
334:
331:
330:
326:
310:
299:
293:
290:
287:
284:
281:
278:
271:
264:
261:
255:
252:
249:
246:
243:
240:
237:
234:
231:
228:
221:
220:
219:
217:
216:
197:
190:
186:
180:
177:
174:
171:
168:
165:
162:
159:
156:
149:
148:
147:
145:
141:
137:
133:
129:
126:
124:
119:
115:
108:
106:
104:
99:
95:
87:
85:
82:
78:
77:Down syndrome
68:
64:
62:
57:
53:
49:
45:
44:pediatricians
41:
32:
19:
958:. Retrieved
954:
945:
934:. Retrieved
932:. 2019-01-23
929:
920:
877:
873:
863:
820:
816:
806:
795:. Retrieved
791:
782:
771:. Retrieved
767:
758:
747:. Retrieved
743:
734:
723:. Retrieved
719:
710:
699:. Retrieved
695:
685:
675:, retrieved
653:
643:
618:
614:
604:
589:
572:
539:
535:
528:
511:
454:
434:
413:Prader Willi
406:
397:
389:
378:
372:
366:
348:
347:
341:
335:
327:
213:
212:
143:
139:
135:
131:
130:
127:
122:
117:
113:
112:
91:
73:
40:growth chart
39:
37:
930:www.cdc.gov
792:Mayo Clinic
744:Mayo Clinic
342:Underweight
42:is used by
1015:Pediatrics
960:2021-09-20
936:2021-09-20
797:2021-09-13
773:2021-09-13
749:2021-09-13
725:2021-09-13
701:2024-08-06
677:2021-09-13
536:Pediatrics
503:References
336:Overweight
894:1598-6357
837:0003-9888
534:Growth".
195:Δ
184:Δ
1009:Category
996:Archived
912:26130954
635:12649571
564:20425748
460:See also
350:Bone age
132:Velocity
903:4479945
855:3058044
846:1779032
556:7651784
497:Obesity
355:puberty
329:Obesity
101:by the
910:
900:
892:
853:
843:
835:
668:
633:
562:
554:
415:, and
54:, and
52:weight
48:height
581:(PDF)
560:S2CID
520:(PDF)
908:PMID
890:ISSN
851:PMID
833:ISSN
666:ISBN
631:PMID
552:PMID
423:and
79:and
898:PMC
882:doi
841:PMC
825:doi
658:doi
623:doi
544:doi
1011::
953:.
928:.
906:.
896:.
888:.
878:30
876:.
872:.
849:.
839:.
831:.
821:63
819:.
815:.
790:.
766:.
742:.
718:.
694:.
664:,
652:,
629:.
619:59
617:.
613:.
558:.
550:.
540:96
538:.
447:.
439:,
411:,
357:.
125:.
50:,
38:A
963:.
939:.
914:.
884::
857:.
827::
800:.
776:.
752:.
728:.
704:.
660::
637:.
625::
598:.
566:.
546::
311:2
307:]
303:)
300:m
297:(
294:t
291:h
288:g
285:i
282:e
279:h
276:[
272:/
268:)
265:g
262:k
259:(
256:t
253:h
250:g
247:i
244:e
241:w
238:=
235:I
232:M
229:B
198:t
191:/
187:q
181:=
178:y
175:t
172:i
169:c
166:o
163:l
160:e
157:v
144:Δ
140:t
136:q
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
